| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Jan 03, 2024 | Sale | $29.46 | 5,843 | 172,135 | 54,372 | Jan 05, 2024, 04:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Jan 04, 2023 | Sale | $37.21 | 2,574 | 95,779 | 25,687 | Jan 06, 2023, 05:26 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Jan 01, 2022 | Sale | $112.24 | 1,051 | 117,964 | 10,922 | Mar 03, 2022, 08:00 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Nov 05, 2021 | Option Exercise | $12.62 | 2,400 | 30,288 | 11,114 | Nov 09, 2021, 06:08 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Nov 05, 2021 | Sale | $132.72 | 2,400 | 318,535 | 9,914 | Nov 09, 2021, 06:08 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Oct 14, 2021 | Option Exercise | $12.62 | 2,400 | 30,288 | 11,114 | Oct 15, 2021, 07:02 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Oct 14, 2021 | Sale | $128.44 | 2,400 | 308,249 | 10,563 | Oct 15, 2021, 07:02 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Sep 24, 2021 | Option Exercise | $12.62 | 7,923 | 99,988 | 8,714 | Sep 27, 2021, 04:15 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Sep 21, 2021 | Option Exercise | $12.62 | 2,400 | 30,288 | 3,191 | Sep 23, 2021, 05:48 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Sep 21, 2021 | Sale | $149.81 | 2,400 | 359,544 | 791 | Sep 23, 2021, 05:48 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Aug 30, 2021 | Sale | $158.04 | 2,400 | 379,300 | 2,991 | Sep 01, 2021, 07:32 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Aug 30, 2021 | Option Exercise | $12.62 | 2,400 | 30,288 | 3,191 | Sep 01, 2021, 07:32 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Aug 09, 2021 | Option Exercise | $12.62 | 2,400 | 30,288 | 3,191 | Aug 11, 2021, 04:50 PM | |
| NTLA | Intellia Therapeutics, Inc. | Lebwohl David | EVP, Chief Medical Officer | Aug 09, 2021 | Sale | $164.05 | 2,400 | 393,720 | 791 | Aug 11, 2021, 04:50 PM |
Menu